Dexpramipexole Uses, Dosage, Side Effects and more
Dexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)).
| Trade Name | Dexpramipexole |
| Generic | Dexpramipexole |
| Dexpramipexole Other Names | Dexpramipexole |
| Type | |
| Formula | C10H17N3S |
| Weight | Average: 211.33 Monoisotopic: 211.114318733 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
